CORDA Investment Management LLC. Grows Stock Position in Kenvue Inc. $KVUE

CORDA Investment Management LLC. boosted its stake in shares of Kenvue Inc. (NYSE:KVUE) by 0.7% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,250,494 shares of the company’s stock after purchasing an additional 8,465 shares during the quarter. Kenvue makes up 1.9% of CORDA Investment Management LLC.’s investment portfolio, making the stock its 25th biggest holding. CORDA Investment Management LLC.’s holdings in Kenvue were worth $26,173,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also made changes to their positions in KVUE. Pittenger & Anderson Inc. purchased a new stake in shares of Kenvue during the first quarter worth approximately $30,000. TruNorth Capital Management LLC purchased a new position in Kenvue in the first quarter worth approximately $36,000. Truvestments Capital LLC acquired a new position in Kenvue during the 1st quarter worth approximately $37,000. Trust Co. of Vermont grew its holdings in Kenvue by 266.8% during the 2nd quarter. Trust Co. of Vermont now owns 1,581 shares of the company’s stock worth $33,000 after acquiring an additional 1,150 shares in the last quarter. Finally, Clal Insurance Enterprises Holdings Ltd increased its position in shares of Kenvue by 378.5% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 1,627 shares of the company’s stock valued at $39,000 after purchasing an additional 1,287 shares during the last quarter. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Analyst Ratings Changes

KVUE has been the subject of several recent analyst reports. Citigroup decreased their price objective on shares of Kenvue from $20.00 to $17.00 and set a “neutral” rating for the company in a research report on Thursday, October 9th. Rothschild Redb upgraded Kenvue from a “hold” rating to a “strong-buy” rating in a research note on Friday, September 26th. Zacks Research raised Kenvue to a “strong sell” rating in a report on Monday, August 11th. Redburn Partners set a $22.00 price objective on Kenvue in a report on Friday, September 26th. Finally, Bank of America cut their target price on Kenvue from $25.00 to $21.00 and set a “buy” rating on the stock in a research report on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, nine have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $21.18.

Kenvue Stock Performance

NYSE KVUE opened at $15.30 on Monday. The company has a fifty day moving average of $18.54 and a two-hundred day moving average of $21.02. The company has a market capitalization of $29.37 billion, a PE ratio of 20.68, a P/E/G ratio of 2.20 and a beta of 0.72. Kenvue Inc. has a 1 year low of $14.05 and a 1 year high of $25.17. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.98 and a quick ratio of 0.68.

Kenvue (NYSE:KVUE) last posted its earnings results on Thursday, August 7th. The company reported $0.29 earnings per share for the quarter, beating the consensus estimate of $0.28 by $0.01. The business had revenue of $3.84 billion during the quarter, compared to the consensus estimate of $3.94 billion. Kenvue had a return on equity of 20.06% and a net margin of 9.37%.The business’s quarterly revenue was down 4.0% on a year-over-year basis. During the same period in the previous year, the business earned $0.32 EPS. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. As a group, analysts expect that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, August 27th. Stockholders of record on Wednesday, August 13th were issued a $0.2075 dividend. The ex-dividend date of this dividend was Wednesday, August 13th. This is an increase from Kenvue’s previous quarterly dividend of $0.21. This represents a $0.83 annualized dividend and a dividend yield of 5.4%. Kenvue’s dividend payout ratio is currently 112.16%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.